查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225536

體內 CRO 市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概覽

  • 到 2022 年，全球體內 CRO 市場規模將達到 46 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 74 億美元，顯示 2023 年至 2028 年之間的增長率 (CAGR) 為 8.07%。
  • 體內合同研究組織 (CRO) 是根據合同開展廣泛生物製藥研究的機構。 我們通過提供外包服務支持製藥和生物技術公司開發有效的藥物、疫苗和醫療設備。 與體外 CRO 相比，體內 CRO 處理在體內進行的研究，進行人體臨床試驗以評估藥物安全性和有效性，而不是對分離的細胞或組織進行測試。 我們幫助研究機構管理複雜的醫學測試，以最低的成本開發有效的藥物，並通過避免延遲招募、資金和臨床準備來優化工作流程。 因此，體內 CRO 具有廣泛的應用，包括疼痛管理、腫瘤學以及中樞神經系統 (CNS) 損傷和其他疾病的治療。 現在分為囓齒類和非囓齒類。

體內CRO市場趨勢

  • 各種心血管疾病(尤其是老年人)的患病率不斷上升，以及對有效藥物和新的基於腫瘤的診斷和治療療法的需求不斷增長，是市場增長的主要驅動力。 在其他活動中，合同研究開發和製造組織 (CRDMO) 對活性藥物成分 (API) 臨床規模製造的需求不斷增加，以及從單克隆抗體向生物仿製藥的轉變正在成為增長動力。 此外，日益嚴重的健康問題促使生物技術公司與 CRO 合作開發有效的新型疫苗，尤其是在 COVID-19 流行期間，這有助於市場增長。 此外，在臨床前試驗期間廣泛使用體內 CRO 進行毒理學和藥代動力學研究也推動了市場增長。 除此之外，生物等效性的出現、仿製藥的激增、專利到期的增加以及個性化藥物設計的持續研發 (R&D) 活動為市場帶來了光明的前景。

主要市場細分

  • IMARC Group 分析了全球體內 CRO 市場報告每個子部分的主要趨勢，並預測了 2023 年至 2028 年在全球、區域和國家層面的情況。 該報告根據類型、GLP 類型和適應症對市場進行分類。

按類型細分

  • 囓齒動物
  • 大鼠
  • 鼠標
  • 其他
  • 非囓齒動物

按 GLP 類型細分

  • 非 GLP
  • 內部
  • 外包
  • GLP 毒理學
  • 內部
  • 外包

按適應症分類

  • 自身免疫性疾病和炎症性疾病
  • 類風濕性關節炎
  • 多發性硬化症
  • 骨關節炎
  • 腸易激綜合徵
  • 其他
  • 疼痛管理
  • 慢性疼痛
  • 劇痛
  • 腫瘤學
  • 血癌
  • 實體癌
  • 其他
  • 中樞神經系統疾病
  • 癲癇症
  • 帕金森病
  • 亨廷頓舞蹈症
  • 中風
  • 創傷性腦損傷
  • 肌萎縮側索硬化
  • 肌肉再生
  • 其他
  • 糖尿病
  • 肥胖
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

本報告中回答的關鍵問題

  • 全球體內 CRO 市場迄今為止發生了怎樣的變化，未來又將發生怎樣的變化？
  • COVID-19 對全球體內 CRO 市場有何影響？
  • 您的主要區域市場是什麼？
  • 按類型劃分的市場細分是什麼？
  • 基於 GLP 類型的市場細分是什麼？
  • 基於指示的市場細分是什麼？
  • 行業價值鏈中有哪些不同階段？
  • 該行業的主要驅動因素和挑戰是什麼？
  • 全球體內 CRO 市場的結構如何？主要參與者有哪些？
  • 您所在行業的競爭力如何？

內容

第1章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第4章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球體內 CRO 市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 囓齒動物
    • 市場趨勢
    • 主要細分市場
      • 大鼠
      • 鼠標
      • 其他
    • 市場預測
  • 非囓齒動物
    • 市場趨勢
    • 市場預測

第 7 章按 GLP 類型劃分的市場細分

  • 非 GLP
    • 市場趨勢
    • 主要細分市場
      • 內部
      • 外包
    • 市場預測
  • GLP 毒理學
    • 市場趨勢
    • 主要細分市場
      • 內部
      • 外包
    • 市場預測

第 8 章按適應症劃分的市場細分

  • 自身免疫性疾病和炎症性疾病
    • 市場趨勢
    • 主要細分市場
      • 類風濕性關節炎
      • 多發性硬化症
      • 骨關節炎
      • 腸易激綜合徵
      • 其他
    • 市場預測
  • 疼痛管理
    • 市場趨勢
    • 主要細分市場
      • 慢性疼痛
      • 劇痛
    • 市場預測
  • 腫瘤科
    • 市場趨勢
    • 主要細分市場
      • 血癌
      • 實體癌
      • 其他
    • 市場預測
  • 中樞神經系統疾病
    • 市場趨勢
    • 主要細分市場
      • 癲癇症
      • 帕金森病
      • 亨廷頓舞蹈症
      • 中風
      • 創傷性腦損傷
      • 肌萎縮側索硬化
      • 肌肉再生
      • 其他
    • 市場預測
  • 糖尿病
    • 市場趨勢
    • 市場預測
  • 肥胖
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 10 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第11章價值鏈分析

第12章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Charles River Laboratories International Inc.
    • Evotec SE
    • ICON plc
    • Iris Pharma(ABIONYX Pharma)
    • Labcorp Drug Development(Laboratory Corporation of America Holdings)
    • North American Science Associates LLC
    • Parexel International Corporation
    • Pharmaceutical Product Development Inc.(Thermo Fisher Scientific Inc.)
    • Pronexus Analytical AB
    • Syneos Health
    • WuXi AppTec
Product Code: SR1423A377_Report

Market Overview:

  • The global in-vivo CRO market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.07% during 2023-2028.
  • In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual basis. They support pharmaceutical and biotechnology companies in formulating effective drugs, vaccines, and medical devices by providing outsourcing services. As compared to in-vitro CRO, in-vivo CRO deals with the research performed within the living organism and conducts human clinical trials to assess the safety and efficacy of the drugs instead of organizing examinations on removed cells and tissues. They aid research institutions in managing complex medical testing, developing effective medications at minimal costs, and optimizing workflow by avoiding delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CRO finds extensive application in pain management, oncology, and treating central nervous system (CNS) injuries and other disorders. Currently, they are bifurcated into rodent- and non-rodent-based types.

In-vivo CRO Market Trends:

  • The increasing prevalence of various cardiovascular ailments, especially amongst the geriatric population, and the growing need for effective medications and novel oncology-based therapies for diagnosis and treatment are primarily driving the market growth. Additionally, the rising demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) and the shifting inclination toward biosimilars over format monoclonal antibodies are acting as other growth-inducing factors. Furthermore, the fueling health concerns have prompted biotechnology companies to engineer effective novel vaccines in collaboration with CRO, especially during the COVID-19 pandemic, which is contributing to the market growth. Moreover, the extensive utilization of in-vivo CRO to perform toxicology and pharmacokinetic studies during preclinical activities is impelling the market growth. Apart from this, the advent of bioequivalence, rapid growth in generics, ongoing patent expirations, and continuous research and development (R&D) activities to engineer personalized medicines are creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global in-vivo CRO market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, GLP type and indication.

Breakup by Type:

  • Rodent
  • Rats
  • Mice
  • Others
  • Non-Rodent

Breakup by GLP Type:

  • Non-GLP
  • In House
  • Outsourcing
  • GLP Toxicology
  • In House
  • Outsourcing

Breakup by Indication:

  • Autoimmune/Inflammation Conditions
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Osteoarthritis
  • Irritable Bowel Syndrome
  • Others
  • Pain Management
  • Chronic Pain
  • Acute Pain
  • Oncology
  • Blood Cancer
  • Solid Tumor
  • Others
  • CNS Conditions
  • Epilepsy
  • Parkinson's Disease
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury
  • ALS
  • Muscle Regeneration
  • Others
  • Diabetes
  • Obesity
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

Key Questions Answered in This Report:

  • How has the global in-vivo CRO market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global in-vivo CRO market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the GLP type?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global in-vivo CRO market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Rodent
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Rats
      • 6.1.2.2 Mice
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-Rodent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by GLP Type

  • 7.1 Non-GLP
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 In House
      • 7.1.2.2 Outsourcing
    • 7.1.3 Market Forecast
  • 7.2 GLP Toxicology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 In House
      • 7.2.2.2 Outsourcing
    • 7.2.3 Market Forecast

8 Market Breakup by Indication

  • 8.1 Autoimmune/Inflammation Conditions
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Rheumatoid Arthritis
      • 8.1.2.2 Multiple Sclerosis
      • 8.1.2.3 Osteoarthritis
      • 8.1.2.4 Irritable Bowel Syndrome
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Pain Management
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Chronic Pain
      • 8.2.2.2 Acute Pain
    • 8.2.3 Market Forecast
  • 8.3 Oncology
    • 8.3.1 Market Trends
    • 8.3.2 Key Segments
      • 8.3.2.1 Blood Cancer
      • 8.3.2.2 Solid Tumor
      • 8.3.2.3 Others
    • 8.3.3 Market Forecast
  • 8.4 CNS Conditions
    • 8.4.1 Market Trends
    • 8.4.2 Key Segments
      • 8.4.2.1 Epilepsy
      • 8.4.2.2 Parkinson's Disease
      • 8.4.2.3 Huntington's Disease
      • 8.4.2.4 Stroke
      • 8.4.2.5 Traumatic Brain Injury
      • 8.4.2.6 ALS
      • 8.4.2.7 Muscle Regeneration
      • 8.4.2.8 Others
    • 8.4.3 Market Forecast
  • 8.5 Diabetes
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Obesity
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Evotec SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 ICON plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Iris Pharma (ABIONYX Pharma)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 North American Science Associates LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pronexus Analytical AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Syneos Health
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2022
  • Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2022
  • Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2022
  • Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2022
  • Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
  • Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
  • Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million US$), 2023-2028
  • Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: In-vivo CRO Market: Competitive Structure
  • Table 7: Global: In-vivo CRO Market: Key Players